Chubb Limited (CB)
(Delayed Data from NYSE)
$288.87 USD
+0.31 (0.11%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $288.18 -0.69 (-0.24%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$288.87 USD
+0.31 (0.11%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $288.18 -0.69 (-0.24%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Zacks News
Chubb Limited was formerly known as ACE Limited. ACE Limited after acquiring The Chubb Corp in Jan 2016 assumed the name of Chubb. Headquartered in Zurich, Switzerland, the company boasts being one of the world’s largest providers of property and casualty (P&C) insurance and reinsurance and largest publicly traded P&C insurer, based on market capitalization of $56.9 billion. Chubb has diversified through acquisitions into many specialty lines, including marine, medical risk, excess property, environmental and terrorism insurance and has local operations in 54 countries and territories. Chubb provides specialized insurance products such as personal accident, supplemental health and life insurance to individuals in select countries. Its reinsurance operations include both P&C and life companies.
AON's Q4 Earnings Miss on Higher Expenses, '23 FCF Jumps 5%
by Zacks Equity Research
AON expects interest expenses for first-quarter 2024 to be $120 million.
Top Research Reports for Abbott, T-Mobile & Booking
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) Booking Holdings Inc. (BKNG).
MetLife (MET) Q4 Earnings Miss on High Costs & Weak EMEA Unit
by Zacks Equity Research
MetLife's (MET) Q4 results took a hit from increased policyholder benefits and claims, partly offset by expanding volumes in the Group Benefits and Latin America units.
Chubb (CB) Q4 Earnings Beat Estimates on Underwriting Strength
by Zacks Equity Research
Chubb's (CB) fourth-quarter results reflect record underwriting income, improved combined ratio across most of the segments and higher premium growth across all the segments.
Chubb (CB) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Chubb (CB) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Chubb (CB) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Chubb (CB) delivered earnings and revenue surprises of 63.71% and 3.92%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Chubb (CB) Ahead of Earnings?
by Zacks Equity Research
Chubb (CB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is a Beat in Store for Chubb Limited (CB) in Q4 Earnings?
by Zacks Equity Research
Chubb Limited's (CB) performance is likely to have benefited from rate increases, favorable prior period reserve development and strong renewal retention.
Ahead of Chubb (CB) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Chubb (CB), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
Hanover Insurance Group (THG) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Hanover Insurance (THG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Higher Costs Affect American Express' (AXP) Q4 Earnings?
by Abhiroop Bhaduri
American Express' (AXP) fourth-quarter results are likely to reflect rising interest income and average Worldwide Card Member Loans.
Can Higher Costs Affect Virtu Financial's (VIRT) Q4 Earnings?
by Zacks Equity Research
Virtu Financial's (VIRT) fourth-quarter results are likely to reflect higher average adjusted net trading income per day, especially in the Market Making segment.
Chubb (CB) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Chubb (CB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is a Beat in Store for Marsh & McLennan (MMC) in Q4 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) fourth-quarter results are likely to reflect robust international operations in the Risk and Insurance Services unit.
W.R. Berkley (WRB) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
W.R. Berkley's (WRB) fourth-quarter results are likely to reflect higher premiums, partially offset by higher expenses.
What's in Store for Progressive (PGR) This Earnings Season?
by Zacks Equity Research
Progressive's (PGR) fourth-quarter earnings are likely to have benefited from improved rates, solid policies in force and higher retention in its strong Vehicle and Property businesses.
Here's Why CME Group (CME) Deserves a Spot in Your Portfolio
by Zacks Equity Research
CME Group's (CME) global presence, compelling product portfolio, focus on over-the-counter clearing services and effective capital deployment poise it well for growth.
Here's Why Chubb (CB) is a Strong Momentum Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Travelers (TRV) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Travelers (TRV) delivered earnings and revenue surprises of 39.09% and 0.24%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Can Higher Expenses Affect Synchrony's (SYF) Q4 Earnings?
by Zacks Equity Research
Synchrony's (SYF) fourth-quarter results are likely to reflect rising total purchase volumes and lower net interest margins.
Cboe Global (CBOE) Up 53% in a Year: Time to Add to Portfolio?
by Zacks Equity Research
Cboe Global's (CBOE) strong market position, global reach, proprietary products' strength and solid capital position poise it well for growth.
CB vs. TKOMY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CB vs. TKOMY: Which Stock Is the Better Value Option?
Marsh & McLennan (MMC) Up 14% in a Year: Upside Potential Left?
by Zacks Equity Research
Growth in the Latin America and Asia regions is expected to buoy Marsh & McLennan's (MMC) results.
Is a Beat in Store for Travelers (TRV) This Earnings Season?
by Zacks Equity Research
Improved pricing, solid renewal rate change, strong retention and exposure growth are likely to aid Travelers Companies' (TRV) fourth-quarter results.